Breaking News

Olon Expands Peptides Capacity and Capabilities

Invests €30 million in Settimo Torinese Biotech Center.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

As part of its strategy for global growth and the enhancement of internal expertise focusing on biotech, Olon has unveiled its two-year plan for investment in the Settimo Torinese Biotech Center in Italy. The plan, worth €30 million, will be implemented over the following two-year period, with the aim of significantly expanding the capacity and expertise of the Settimo Torinese Biotech Hub. The Hub is a strategic asset for the group’s global manufacturing network, because, relying on experien...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters